Monoamine Oxidase Inhibitors
Links shared publicly online about this topic
Toxicity, Monoamine Oxidase Inhibitor: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Neurotransmitters are generally monoamines. They are manufactured, stored in vesicles in the nerve terminals, and then released through the plasma membrane into the synaptic cleft. When released into the synaptic space, neurotransmitters are either reabsorbed into ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 3, 2010 at 10:05 pm By:
MAOI poisoning can occur from overdose, drug-food interactions, or drug-drug interactions. Learn more. http://bit.ly/9CApFs
Bipolar Disorder Medication Spotlight: Monoamine Oxidase Inhibitors (MAOI’s) | Bipolar Beat
zz.gd — “With this post, we continue our sort-of-biweekly series on medications used to treat bipolar disorder and related symptoms. Two weeks ago, we covered an older” View full resource at zz.gd
Most Recently Shared on August 21, 2009 at 12:04 pm By:
Bipolar Beat: Bipolar Disorder Medication Spotlight: Monoamine Oxidase Inhibitors (MAOI's) @http://zz.gd/2b409c
Psychiatry Article | Monoamine Oxidase
mdlinx.com — “Monoamine oxidase inhibitor usage in Hawaii” View full resource at mdlinx.com
Most Recently Shared on December 27, 2010 at 6:51 pm By:
Monoamine oxidase inhibitor usage in Hawaii: Asian Journal of Psychiatry http://bit.ly/hGkI6l #PSY
Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology
touchneurology.com — “Parkinson's disease, monoamine oxidase type B (MAO-B) inhibitors, rasagiline, selegiline, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, Rasagiline Mesylate (TVP-1012) in Early Monotherapy for PD Outpatients (TEMPO)” View full resource at touchneurology.com
Most Recently Shared on October 24, 2010 at 12:15 pm By:
Neurology Article | Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinsons Disease
mdlinx.com — “Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Treatment of Parkinsons Disease” View full resource at mdlinx.com
Most Recently Shared on September 29, 2011 at 8:04 am By:
Controversies in Neurology: Why Monoamine Oxidase B Inhibitors Could Be a Good Choice for the Initial Tre... http://t.co/Sss1BxR7 #neuro
Platelet Monoamine Oxidase Activity and Aggressive Obsessions | Psychiatry
touchpsychiatry.com — “Obsessive--compulsive disorder (OCD) is characterised by the repeated eruption in the mind of unwanted ideas, images or impulses described by the term --'obsessions--™.” View full resource at touchpsychiatry.com
Most Recently Shared on February 17, 2011 at 12:54 pm By:
Platelet Monoamine Oxidase Activity and Aggressive Obsessions http://bit.ly/gstb3z
Arch Gen Psychiatry -- Abstract: Monoamine Oxidase A Binding in the Prefrontal and Anterior Cingulate Cortices During Acute Withdrawal From Heavy Cigarette Smoking, August 2011, Bacher et al. 68 (8): 817
archpsyc.ama-assn.org — “Archives of General Psychiatry, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed articles about psychiatry and related fields” View full resource at archpsyc.ama-assn.org
Most Recently Shared on August 2, 2011 at 10:05 pm By:
Withdrawal from heavy cigarette smoking associated with brain imaging changes in regions related to mood regulation http://t.co/GIuLZ8M
Access : Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation : Immunology and Cell Biology
nature.com — “Immunology and Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology. Areas that are covered include but are not limited to: Cellular immunology, Innate and adaptive immunity, Immune responses to pathogens,Tumour immunology,Immunopathology, Immunotherapy, Immunogenetics, Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)” View full resource at nature.com
Most Recently Shared on June 30, 2011 at 1:59 am By:
Apocynin may be useful in the treatment of inflammatory diseases induced by oxidative stress through NOX activity http://bit.ly/kIQ3oB
Study confirms Azilect as a selective MAO-B inhibitor
news-medical.net — “Teva Neuroscience Inc. today announced the publication of a study demonstrating the selectivity of Azilect® (rasagiline tablets) for inhibition of MAO-B (monoamine oxidase-B) at the maximum approved dose of 1 mg/day. The data was published in the Journal of Clinical Pharmacology OnlineFirst on May 5, 2010.” View full resource at news-medical.net
Most Recently Shared on June 4, 2010 at 11:52 am By:
Medicare News: Study confirms Azilect as a selective MAO-B inhibitor: Teva Neuroscience Inc. today announced the p... http://bit.ly/9HHPMA
Depression: New Medications On The Horizon | Psych Central
psychcentral.com — “With the advent of monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) in the 1950s, depression treatment was revolutionized. These” View full resource at psychcentral.com
Most Recently Shared on January 18, 2011 at 5:55 pm By:
New Article: Depression: New Medications On The Horizon http://bit.ly/gepMYR
DailyMed: About DailyMed
dailymed.nlm.nih.gov — “DailyMed: About DailyMed” View full resource at dailymed.nlm.nih.gov
Most Recently Shared on October 10, 2010 at 3:35 am By:
SCOT-TUSSIN DIABETES COUGH FORMULA WITH DM (Dextromethorphan Hydrobromide) Liquid [SCOT-TUSSIN Pharmacal Co., Inc.... http://bit.ly/bIHoH5
FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
drugs.com — “Azilect (rasagiline) is used for Parkinson’s Disease. Information from Drugs.com includes Azilect side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 15, 2009 at 10:13 pm By:
FDA Approves New Prescribing Information for Azilect Reducing Medication and Food Restrictions - http://bit.ly/8BJT52
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions
medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) r” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2009 at 8:11 pm By:
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://mnt.to/3vwn
CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression
medicalnewstoday.com — “CeNeRx BioPharma, Inc., reported that it has initiated a Phase II trial of its new formulation of TriRima™, the company's novel antidepressant in development as monotherapy for treatment res” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2011 at 3:05 pm By:
CeNeRx Initiates Phase II Trial Of TriRima™ As Monotherapy In Treatment Resistant Depression http://mnt.to/3PJS #depression
Psychiatry Medical News about Depressive Disorder
mdlinx.com — “Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence” View full resource at mdlinx.com
Most Recently Shared on January 8, 2010 at 9:50 am By:
Psychiatry: Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptak http://url4.eu/14juU
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

